Investing.com - Amgen reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.25 on revenue of $6.24B. Analysts polled by Investing.com EPS of $4.12 on revenue of $6.11B.
Amgen 's are up 10% and is trading at $250.59 , still down 3.83% from its 52 week high of $258.70 set on Monday, May 10, 2021.
Amgen shares gained 0.72% to trade at $250.59 in after-hours trade the report.
Amgen follows other major Healthcare sector earnings this month
Amgen's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar